News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
78 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19274)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1750)
Day
1 (121)
2 (97)
3 (8)
5 (6)
6 (79)
7 (151)
8 (89)
9 (80)
10 (30)
13 (139)
14 (106)
15 (102)
16 (135)
17 (48)
19 (25)
20 (84)
21 (88)
22 (116)
23 (109)
24 (78)
26 (6)
27 (53)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
Press Releases
Ipsen provides update on Phase III BOLD trial in biliary atresia
July 24, 2026
·
9 min read
Press Releases
Almirall H1 2026 Results
July 24, 2026
·
8 min read
Press Releases
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
July 24, 2026
·
6 min read
Press Releases
Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results
July 24, 2026
·
5 min read
Obesity
Roche cans one Carmot obesity asset as another shows best-in-class potential
Acmopatide met the main goal of a Phase 2 study in type 1 diabetes, but Roche is axing the investigational drug to prioritize enicepatide for weight loss, type 2 diabetes and cardiovascular outcomes. Both assets come from the $2.7 billion buy of Carmot Therapeutics.
July 24, 2026
·
2 min read
·
Tristan Manalac
Earnings
Summit has less than a year of cash runway left as PD-1/VEGF verdict nears
Summit’s star asset is the PD-1/VEGF bispecific ivonescimab, which this week produced promising survival data from a late-stage global trial in non-small cell lung cancer. The FDA review is ongoing with a decision expected by Nov. 14.
July 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
July 24, 2026
·
2 min read
Press Releases
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
July 24, 2026
·
9 min read
Press Releases
CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer
July 24, 2026
·
18 min read
Press Releases
MannKind Announces $50 Million Private Placement
July 24, 2026
·
4 min read
Previous
5 of 8
Next
